Close
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
View All Publications - Ramon Cancino
Virtual Access to Subspecialty Care
Practice Transformation to Improve Cancer Screening Outcomes at an Academic Medical Center
Mays Cancer Center Partners with Nation’s Top Cancer Organizations to Endorse Initiative to Increase Lung Cancer Screening in the United States
Joint call to action urges individuals, providers and insurers to increase access to and utilization of low-dose CT screening for those at high risk for lung cancer Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO (Nov. 1, 2022) – Lung cancer is the leading cause of cancer death in the United States, accounting for almost 25% of […]
Professor and chair receives $1.5 million UT System Faculty STARs award to advance cancer drug development
Reuben S. Harris, PhD, professor and chair in the Department of Biochemistry and Structural Biology at the University of Texas Health Science Center at San Antonio (UT Health San Antonio), has received a UT System Faculty Science and Technology Acquisition and Retention (STARs) award in the amount of $1.5 million to establish his laboratory, assist […]
Living Beyond Cancer symposium scheduled for January
Cancer survivors, cancer patients, friends, family and caregivers are invited to attend Living Beyond Cancer A-Z, a free symposium on Jan. 21, put on by the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center. It will feature a full day of learning, empowerment and discovery and will take place […]